These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 21855608

  • 21. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes.
    de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJ.
    Eur J Clin Invest; 2000 Mar; 30(3):248-51. PubMed ID: 10692002
    [Abstract] [Full Text] [Related]

  • 22. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [Abstract] [Full Text] [Related]

  • 23. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ, Kartikasari AE, Georgiou NA.
    Hemoglobin; 2008 Jan; 32(1-2):123-34. PubMed ID: 18274990
    [Abstract] [Full Text] [Related]

  • 24. [Quantification of iron overload].
    Guyader D, Gandon Y.
    Bull Acad Natl Med; 2000 Jan; 184(2):337-47; discussion 347-8. PubMed ID: 10989542
    [Abstract] [Full Text] [Related]

  • 25. Pathogenesis and management of iron toxicity in thalassemia.
    Hershko C.
    Ann N Y Acad Sci; 2010 Aug; 1202():1-9. PubMed ID: 20712765
    [Abstract] [Full Text] [Related]

  • 26. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 27. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB, Divitini ML, Gunton JE, Olynyk JK, Beilby JP, McQuillan B, Hung J, Knuiman MW.
    Clin Endocrinol (Oxf); 2015 Apr 28; 82(4):525-32. PubMed ID: 24953981
    [Abstract] [Full Text] [Related]

  • 28. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
    Olcay L, Serteser M, Kolay M, Balci HF, Yildirim ÜM, Tekgündüz SA, Hazirolan T, Terzi YK.
    J Pediatr Hematol Oncol; 2017 Aug 28; 39(6):425-439. PubMed ID: 28731917
    [Abstract] [Full Text] [Related]

  • 29. Evidence for a low Km transporter for non-transferrin-bound iron in isolated rat hepatocytes.
    Barisani D, Berg CL, Wessling-Resnick M, Gollan JL.
    Am J Physiol; 1995 Oct 28; 269(4 Pt 1):G570-6. PubMed ID: 7485509
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
    Breuer W, Ghoti H, Shattat A, Goldfarb A, Koren A, Levin C, Rachmilewitz E, Cabantchik ZI.
    Am J Hematol; 2012 Jan 28; 87(1):55-61. PubMed ID: 22125177
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron-carbohydrate administration.
    Garbowski MW, Cabantchik I, Hershko C, Hider R, Porter JB.
    Am J Hematol; 2023 Mar 28; 98(3):533-540. PubMed ID: 36565452
    [Abstract] [Full Text] [Related]

  • 35. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY, Chang SD, Sreenivasan GM, Tsang PW, Broady RC, Li CH, Zypchen LN.
    Ann Hematol; 2011 Feb 28; 90(2):139-43. PubMed ID: 20721554
    [Abstract] [Full Text] [Related]

  • 36. Regulation of iron transport and the role of transferrin.
    Gkouvatsos K, Papanikolaou G, Pantopoulos K.
    Biochim Biophys Acta; 2012 Mar 28; 1820(3):188-202. PubMed ID: 22085723
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging.
    Roghi A, Poggiali E, Duca L, Mafrici A, Pedrotti P, Paccagnini S, Brenna S, Galli A, Consonni D, Cappellini MD.
    Int J Cardiol; 2015 Nov 15; 199():326-32. PubMed ID: 26241638
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transferrin saturation as a surrogate marker for assessment of labile nontransferrin bound iron in chronic liver disease.
    Oliveira PMC, Espósito BP, Carvente C, Silva GA, Dellavance A, Baldo DC, Ferraz MLG.
    Eur J Gastroenterol Hepatol; 2022 Oct 01; 34(10):1047-1052. PubMed ID: 36052686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.